Cargando…

Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma

The goal of the 1-year observational, multicentre, open-label study reported here was to identify factors influencing adherence to high-dose interferon alfa-2b adjuvant therapy in patients at high risk of recurrence following surgical excision of malignant melanoma. The study was carried out in 23 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Levesque, N., Mitchinson, K., Lawrie, D., Fedorak, L., MacDonald, D., Normand, C., Pouliot, J.F.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259435/
https://www.ncbi.nlm.nih.gov/pubmed/18317583